DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway

The treatment of osteosarcoma (OS) is still mainly surgery combined with systematic chemotherapy, and gene therapy is expected to improve the survival rate of patients. This study aimed to explore the effect of DEP domain 1 protein (DEPDC1) and kinesin super-family protein 4A (KIF4A) in OS and under...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mingming, Zhang, Hang, Gao, Shichang, Huang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972622/
https://www.ncbi.nlm.nih.gov/pubmed/36849972
http://dx.doi.org/10.1186/s13018-023-03572-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972622/
https://www.ncbi.nlm.nih.gov/pubmed/36849972
http://dx.doi.org/10.1186/s13018-023-03572-4

Ejemplares similares